Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 5:32 PM UTC
| NCT Number | NCT07216027 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE2 |
| Target Enrollment | 165 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | May 27, 2026 (May 27, 2026) |
As of July 19, 2026: Clinical trial NCT07216027 is currently recruiting participants. This phase2 study for atopic dermatitis is actively seeking new participants at 4 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07216027 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07216027 was last updated May 27, 2026 (May 27, 2026). HelloStudys verifies this status automatically.